UC Davis CCC receives first SPORE grant for immunotherapy in head and neck cancer

Mayo Clinic performs world’s first known successful total larynx transplant in a patient with active cancer

A multidisciplinary team of doctors at Mayo Clinic in Arizona performed the third known total larynx transplant in the U.S.

July 12, 2024

Vol.50 No.28

In the Archives

The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop

In 1998, lung cancer was the leading cause of cancer deaths in the United States, with 160,000 deaths per year. That statistic inspired Matthew Meyerson, who would soon start working at the Dana-Farber Cancer Institute, to specialize in lung cancer.

July 05, 2024

Vol.50 No.27

Conversation with The Cancer Letter

Robert L. Ferris named executive director of UNC Lineberger—with an additional job as chief of oncology services

Robert L. Ferris, a head-and-neck surgeon and an expert in cancer immunotherapy was named the executive director of UNC Lineberger Comprehensive Cancer Center and the chief of oncology services at UNC Health.

Innovative PET scanner could change the way lung cancer is evaluated and treatment is assessed

Scientists at UC Davis Comprehensive Cancer and the UC Davis Department of Radiology have discovered a novel way to image the unique blood supply of the lungs. Their findings, published in the Journal of Nuclear Medicine, suggest the new method could help determine if lung cancer treatment is working.

June 14, 2024

Vol.50 No.24

Clinical Roundup

Proton therapy demonstrates advantages for head and neck cancer in phase III trial preliminary data

According to preliminary data from a multi-institution phase III trial led by researchers at MD Anderson Cancer Center, intensity modulated proton therapy achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy as part of chemoradiation treatment for patients with oropharyngeal cancer.

June 07, 2024

Vol.50 No.23

In Brief

David Tom Cooke named associate director of Office of Inclusion, Diversity, Equity and Accessibility at UC Davis

David Tom Cooke was named associate director of the Office of Inclusion, Diversity, Equity and Accessibility (IDEAL) at University of California Davis Comprehensive Cancer Center.

May 17, 2024

Vol.50 No.20

UC Davis CCC receives first SPORE grant for immunotherapy in head and neck cancer

YOU MAY BE INTERESTED IN

Mayo Clinic performs world’s first known successful total larynx transplant in a patient with active cancer

The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop

Robert L. Ferris named executive director of UNC Lineberger—with an additional job as chief of oncology services

Innovative PET scanner could change the way lung cancer is evaluated and treatment is assessed

Proton therapy demonstrates advantages for head and neck cancer in phase III trial preliminary data

David Tom Cooke named associate director of Office of Inclusion, Diversity, Equity and Accessibility at UC Davis

Renew today!

Subscriber content

Login